NUS vs USNA
NUS: Nu Skin is an intelligent beauty and wellness company operating a global direct selling platform supported by its own product manufacturing and innovation investments. USNA: An omnichannel health and wellness company transitioning from a legacy direct-selling model to a diversified business featuring nutritional supplements, children's wellness products, and healthy functional foods.
Side-by-side fundamentals
| Metric | NUS | USNA | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $4.77 | $14.66 | |
| Market cap | $232M | $271M | |
| P/E as of 2026-10-08 | 4.38 | 30.83 | NUS lower |
| Net margin | +10.8% | +1.2% | NUS higher |
| Gross margin | +69.4% | +78.3% | USNA higher |
| Operating margin | +4.4% | +4.0% | NUS higher |
| ROE | +19.9% | +2.0% | NUS higher |
| ROA | +11.4% | +1.4% | NUS higher |
| Debt / equity as of 2026-09-03 | 0.28 | 0.03 | USNA lower |
| Revenue growth (YoY) as of 2026-09-03 | -14.2% | +5.7% | USNA higher |
| Revenue CAGR (3y) SEC XBRL | -12.6% | -1.9% | USNA higher |
| Dividend yield as of 2026-09-03 | +5.2% | n/a | |
| Dividend streak (yrs) SEC XBRL | 2 | 0 | NUS higher |
| Beta as of 2026-09-03 | 0.88 | 0.82 | |
| 1-year return as of 2026-10-08 close | -57.6% | -44.7% | USNA higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.